Abstract
Focused Clinical Question: Debates and questions related to the newly developed two-vector system
for classification of periodontal diseases have emerged as to how to accurately assign stage and grade
to the periodontitis cases. The aim of the present manuscript is to demonstrate the essential thought
processes that are needed in utilizing the new periodontitis classification system to diagnose two gray
zone cases.
Summary: Clinical case 1 includes an 83-year old patient diagnosed with periodontitis and classified as
Generalized Stage III Grade B periodontitis, while clinical case 2 , a 73-year old male was classified as
presenting Generalized Stage IV Grade B periodontitis. Although clinical and radiographic evaluations
revealed similarities between the cases, the thought process that includes clinical judgement is
described to guide a more accurate diagnosis following the guidelines of the new classification
system.
Conclusion: The two cases demonstrated here offer an opportunity for clinicians to recognize the
essential role of sound clinical judgment in certain cases when applying the new periodontal disease
classification system and also to clarify questions emerging from implementing this classification
system.
Key words: Staging and grading of periodontal diagnosis, Periodontal Diseases, Periodontal Diagnosis,
Hi,Fi Call Girl In Mysore Road - 7001305949 | 24x7 Service Available Near Me
Gray Zone Cases
1.
2. Rafael Siqueira, Nathalia Andrade, Shan-Huey Yu, Kenneth S . Kornman, Hom-Lay Wang
Challenges And Decision making For The Classification Of
Two Complex Periodontal Cases
2020 Nov 4
4. HOWTO DECIDE
• Periodontitis ???
Ideally done by assessing presence of clinical attachment loss but, if
(i) interproximal attachment loss is present at least at two different, non-adjacent
teeth, and (ii) the observed attachment loss cannot be attributed to traumatic factors
or non-periodontitis related etiologies (e.g., root fracture, endodontic infection,
surgical trauma).
In the absence of interproximal attachment loss, but if attachment loss that
cannot be ascribed to non-periodontitis-related causes is present at buccal or
lingual surfaces, diagnosis of periodontitis requires presence of clinical
attachment loss of ≥ 3mm and probing depth of ≥ 3 mm at ≥ 2 teeth.
5. Clinicians will confirm the presence of attachment loss by corresponding
interproximal alveolar bone loss on radiographs.
Tissue loss needs to encompass a substantial portion of the buccal-lingual
dimension before it can be visualized by conventional radiographs. Thus, absence
of readily discernible bone loss does not preclude presence of frank periodontitis
of incipient severity.
• Stage assessment ???
Stage I and II patients show periodontitis of incipient or moderate
severity, have not lost any teeth due to the disease, and respond predictably to
standard therapy based on the principles of sustainable reduction of the
bacterial burden.
6. In stage III and stage IV periodontitis patients, it is most likely that one or
several intrinsic or environmental risk factors adversely affect the ability of
the host to respond to the bacterial infection and to contain the tissue
damage.
Requires high-level assessment of the patient’s medical history,
radiographs, and probing chart to distinguish between Stage I or II vs
Stage III or IV periodontitis, using two key discriminatory variables that can
distinguish between the two aggregate groups, i.e., the severity of tissue
damage and the presence of periodontitis-associated tooth loss.
8. Selected periapical radiographs that capture one patient’s overall general radiographic
bone loss, which is in the coronal third of the root length. The orange box in the Figure
defines characteristics of Stages I and II, which include the most likely severity of
periodontitis. For this patient. This initial high-level disease assessment guides clinicians to
target Stages I and II based on clinical and radiographic bone loss of patients.
9. Selected periapical radiographs that capture one patient’s overall general radiographic
bone loss, which is in the middle third or beyond of the root length. The orange box in
the Figure defines characteristics of Stages III and IV, which include the most likely
severity of periodontitis for this patient. This initial high-level disease assessment guides
clinicians to target the parameters listed for Stages III and IV based on clinical and
radiographic bone loss of patients.
10. In this step, the clinician needs to study in detail the available full-mouth
periodontal charting and full-mouth series of intra-oral radiographs. The
distinction between Stage I & II periodontitis will be primarily carried out by
evaluating severity of bone loss at areas of the dentition with the most advanced
destruction.
• How to reliably differentiate between bone loss of up to 15% of the root
length vs bone loss extending between 15% and 33% of the root length???
Clear interproximal bone loss within the coronal third of the root length,
means Stage II rather Stage I disease.
Stage I disease is usually characterized by incipient attachment loss in the
presence of early radiographic evidence of disruption in the alveolar bone
support example, a break in the integrity of the lamina dura rather than
pronounced increase in the CEJ-bone crest distance.
11. If the preliminary assessment is that the patient suffers from either Stage III or
Stage IV periodontitis, the distinction between these two stages will be based either on
the amount of tooth loss that can be attributed to periodontitis (1-4 teeth versus 5 or
more teeth lost) or on the presence of the various complexity factors.
The following two central questions that essentially
represent a distillation of the case’s treatment:
(i) does the patient’s extent and severity of
periodontitis constitute a threat for the survival of
individual teeth or rather of the survival of the entire
dentition?
(ii) does the total therapy envisioned to address the sequalae of periodontitis in the
particular patient involve extensive, multi-disciplinary oral rehabilitation?
12. The terms “localized” or “generalized” will be used to describe the extent of the
dentition that is affected by the Stage-defining severity.
E.g., localized Stage III periodontitis, include segments of the dentition with mild or
moderate severity of attachment/bone loss. Acknowledged in the “narrative” portion of the
case description.
• Whether a patient’s Stage can change over time???
If a patient that has been staged at a given time point experiences significant disease
progression or disease recurrence after therapy that results in increased severity and/
or more complex treatment needs, then stage must be shifted upwards at the time of
the subsequent examination, as appropriate.
The severity of attachment loss and /or bone loss can be reduced substantially
from beyond the coronal third to within the coronal third in cases of successful
regeneration therapy, it is advised that the patient retains the Stage originally assigned
prior to the treatment.
13. • Assessment of Grade???
The primary goal of grading is to determine which of two disease paths a
specific patient is traveling on, and use this information to guide the most
appropriate treatment strategy that will lead to successful outcomes.
A “Path 1” patient has minimal likelihood of disease progression, and clinical
treatment responses are expected to be predictable after applying standard principles
of periodontitis treatment based on biofilm disruption and regular plaque control;
in contrast, in a “Path 2”patient, there is an increased likelihood of disease
progression and less predictable clinical response to standard periodontitis prevention
and treatment principles
Done based on three fundamental principles: 1) Not all individuals are equally
susceptible to periodontitis;
2) Periodontitis progression and severity is a function of multifactorial influences on
a patient’s response to the microbial challenge. Multiple factors often interact to
influence clinical phenotypes and
3) Some periodontitis cases require more intensive control of the microbial biofilm
and inflammation than achieved using current principles of care.
14. There are 3 primary goals for Grading a patient with periodontitis:
– To assist in stratifying each patient in terms of which of two general paths best
capture the patient’s periodontitis trajectory.
– To assist new protocol development for management of periodontitis cases that
are less likely to respond to current principles for periodontitis prevention and
treatment.
– To assist in development of additional approaches to management of certain
periodontitis cases that may favorably influence systemic health.
Factors to be assessed to determine the patient’s grade
1. Progression: by longitudinal assessments of radiographic bone loss (RBL) or CAL.
For most patients progression rate must be confirmed using the most severe RBL
observed in relation to patient age (% bone loss / age ratio).
Bone loss assessment as a percentage of root length is inherently a rough estimate based
on the clinician’s interpretation of the most apical location of alveolar bone support,
location of the CEJ, and location of the root apex.
15. The example below (Figure) shows bone loss of approximately 60% or greater of root
length. In a 50-year-old patient, this would represent a greater than 1.0 bone loss / age
ratio, as shown in Table. A maximum bone loss ratio by age >1.0 will classify the patient as
Grade C based on progression rate.
16. 2. Risk Factors: The Grading table lists the two most well-documented risk factors for
periodontitis, namely smoking and diabetes mellitus.
Clinicians should consider a patient’s other systemic factors that may influence progression
of periodontitis and treatment, these may include obesity, chronic inflammatory diseases
such as rheumatoid arthritis, chronic depression, genetic factors, and other factors
from a comprehensive medical history.
3. Systemic Impact Risk: From evidence its clear that presence of certain chronic
inflammatory diseases influences the likelihood of a second chronic disease. Association of
periodontitis with other diseases such as CVS, Type II diabetes and APO is documented
but evidence that treatment of periodontitis will result in predictable benefits with
respect to any of those systemic conditions is rather limited.
4. Biomarkers: It is expected that additional evidence of clinical utility and further
advances with novel biomarkers may better inform objective assessments of Grade.
17.
18. AIM
To demonstrate the essential thought process to utilize the new periodontitis
classification
system in two challenging cases with gray zones that might hinder
straightforward case
definition with stage and grade.
19. Clinical Scenario 1
A 83-year-old male patient was referred (May/2019)
C/C => “I want to have healthy teeth again”.
D/H => His last periodontal maintenance was one month before visiting the clinic.
M/H => congestive heart failure since 2016 .
29. Clinical Scenario 2
73-yead-old male patient was referred on July of 2019.
C/C => “I don’t want to lose my teeth”.
D/H => Scaling and root planing which was done 15 years ago.
M/H => Controlled Hypertension, type 2 diabetes, basal cell carcinoma (removed in
2017)